|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 131.00 AUD | +4.37% |
|
+3.66% | -40.90% |
| 05-18 | Pro Medicus signs 7-year A$90m deal with Beth Israel Lahey Health | RE |
| 05-18 | Pro Medicus Unit Secures AU$90 Million Deal With Beth Israel Lahey Health; Shares Up 7% | MT |
| Capitalization | 13.11B 9.38B 8.06B 7.37B 7B 12.89B 904B 88.25B 34.2B 428B 35.2B 34.45B 1,490B | P/E ratio 2026 * |
54.5x | P/E ratio 2027 * | 69.3x |
|---|---|---|---|---|---|
| Enterprise value | 12.92B 9.24B 7.94B 7.26B 6.9B 12.7B 890B 86.94B 33.7B 421B 34.68B 33.94B 1,468B | EV / Sales 2026 * |
48.8x | EV / Sales 2027 * | 38x |
| Free-Float |
50.74% | Yield 2026 * |
0.66% | Yield 2027 * | 0.78% |
Last Transcript: Pro Medicus Limited
| 1 day | +4.00% | ||
| 1 week | +3.66% | ||
| Current month | -2.87% | ||
| 1 month | -9.84% | ||
| 3 months | +1.07% | ||
| 6 months | -47.86% | ||
| Current year | -40.90% |
| 1 week | 119.24 |  | 132.7 |
| 1 month | 119.24 | | 151.98 |
| Current year | 107.75 | | 223.02 |
| 1 year | 107.75 | | 336 |
| 3 years | 58.6 | | 336 |
| 5 years | 36.54 | | 336 |
| 10 years | 4.2 | | 336 |
| Manager | Title | Age | Since |
|---|---|---|---|
Sam Hupert
CEO | Chief Executive Officer | - | 01/10/2010 |
Anthony Hall
CTO | Chief Tech/Sci/R&D Officer | - | - |
Danny English
DFI | Director of Finance/CFO | - | 16/03/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
Anthony Hall
BRD | Director/Board Member | - | 01/01/1983 |
Peter Kempen
CHM | Chairman | 75 | 01/08/2010 |
Anthony Glenning
BRD | Director/Board Member | - | 01/05/2016 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +2.43% | 0.01% | 33,076 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +4.37% | +3.66% | -53.09% | +115.53% | 9.12B | |
| +3.14% | +2.84% | -32.51% | -1.94% | 25.93B | |
| +1.09% | -1.15% | -19.06% | +50.32% | 5.23B | |
| -9.43% | -12.74% | - | - | 2.44B | |
| -18.72% | -9.50% | - | - | 2.04B | |
| +0.23% | -0.18% | +54.58% | -41.00% | 1.96B | |
| -1.74% | -2.75% | -36.38% | - | 1.2B | |
| 0.00% | -5.76% | -20.86% | -49.58% | 967M | |
| -1.59% | -5.61% | -25.39% | +5.42% | 908M | |
| 0.00% | +7.53% | +19.05% | -58.02% | 851M | |
| Average | -2.30% | +0.34% | -14.21% | +2.96% | 5.06B | |
| Weighted average by Cap. | +1.17% | -3.01% | -30.12% | +24.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 265M 189M 163M 149M 141M 260M 18.25B 1.78B 691M 8.63B 711M 696M 30.09B | 338M 242M 208M 190M 180M 332M 23.29B 2.27B 882M 11.02B 907M 888M 38.4B |
| Net income | 243M 174M 149M 136M 130M 239M 16.71B 1.63B 633M 7.91B 651M 637M 27.56B | 187M 134M 115M 105M 99.94M 184M 12.9B 1.26B 488M 6.1B 502M 492M 21.27B |
| Net Debt | -195M -139M -120M -109M -104M -191M -13.41B -1.31B -508M -6.35B -523M -512M -22.12B | -282M -201M -173M -158M -150M -277M -19.41B -1.9B -735M -9.18B -756M -740M -32B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 19/05/26 | 131.00 $ | +4.37% | 49,483 |
| 18/05/26 | 125.52 $ | +2.79% | 307,321 |
| 15/05/26 | 122.11 $ | +0.42% | 217,174 |
| 14/05/26 | 121.60 $ | -3.11% | 428,489 |
| 13/05/26 | 125.50 $ | -0.34% | 193,229 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- PME Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition